The Microfluidics Market size was estimated at USD 28.71 billion in 2022 and is expected to reach USD 72.10 billion by 2030 at a CAGR of 12.2% during the forecast period of 2023-2030.
Microfluidics is a technological method for investigating the nature and properties of fluids. Its application comprises the employment of a collection of tools for modifying and directing the chemical and biological processes of small quantities of fluids. It is also utilized in the manufacture of microminiaturized devices having multiple tubes and chambers through which fluids flow or are restricted.
.png)
Get more information on Microfluidics Market - Request Free Sample Report
DRIVERS
Increasing technical advancement
The goal of technological advancements in microfluidic components is to improve and simplify healthcare operating processes. Integrated microfluidic components have been employed in research labs for over 20 years. Soft lithography and large-scale microfluidic integration have seen significant advancements in the life sciences and medical research during the last ten years. Because of technological advancements, researchers have been able to increase the complexity and sophistication of experiments that can be performed on a microfluidic chip, which has also enhanced quick development efforts. Microfluidic components are quickly becoming a critical technology in a wide range of industries, including medicine, biosensing, bioactivation, and chemical synthesis. This demonstrates how microfluidics has evolved from a prospective research tool to one used in clinical investigations to collect data using Al. Microfluidics, particularly lab-on-a-chip technology, is an effective technique for the large-scale, cost-efficient, high-throughput, automated, and diverse creation and application of Al.
RESTRAIN
Microfluidics incorporation into existing workflows
The first microfluidic screening equipment hit the market less than a decade ago. Currently, microfluidics technology offers enormous chances for further shrinking and integration of devices, as well as better automation and cost reduction in the drug discovery and development processes. Despite the fact that microfluidics provides value to the process and instruments, it is expected that it will take 10 to 15 years before this technology totally replaces conventional macro-scale research instrumentation. Until such a scenario emerges, the market will see sporadic installments of microfluidic devices, causing producers to be marginalized to some extent by conventional technology providers.
OPPORTUNITY
Microfluidics is being used to broaden the applicability of medication delivery technology.
Implantable medication delivery systems are one example of a technologically advanced technology that can provide significant prospects for market expansion for businesses. This is due to the fact that microfluidics technology enables the creation of portable and wearable products that ensure accurate and dependable drug administration. Insulin pumps are the most common microfluidics-based drug delivery devices, and numerous related micro-pumping techniques are being researched at the moment. More of these gadgets are projected to become available during the next two to three years.
CHALLENGES
Microfluidic device standardization and commercialization
Customer acceptability influences the commercialization of any piece of equipment. several studies support the notion of microfluidics-based devices and provide several assurances about the outcomes gained. However, due to the commercialization of this technology, end-user adoption is restricted, and scalability is unclear. Although this technology has shown promising results in research, it will take a few years for it to be fully implemented in all industries. Investors prefer to put their money into more promising technologies. As a result, researchers are expected to move their focus away from microfluidics technology and into other areas such as the environment or food.
Because of the low incidence and small number of important market competitors in this region, the Russia-Ukraine war is expected to have little impact on the worldwide organ-on-chip industry. However, the impact of raw material imports and exports is predicted to have little impact on the worldwide organ-on-chip market growth over the forecast period.
By Application
Medical/Healthcare
PCR & RT-PCR
Gel Electrophoresis
Microarrays
ELISA
Others
Non-medical
In 2022, Medical/Healthcare segment is expected to held the highest market share of 83.8% and is expected to exhibit a CAGR of 12.6% during the forecast period. Microfluidics is an important technique in biological analysis, chemical synthesis, and information technology. Microfluidics has resulted in several advancements, including minimal reagent usage and maximum information derived from small sample sizes, short and simple assay protocols, improved parallel processing of samples and screening approaches, and accurate spatiotemporal control of cell microenvironments.
By Material
Silicon
Glass
Polymer
polydimethylsiloxane (PDMS)
Others
In 2022, the polydimethylsiloxane (PDMS) segment is expected to dominate the market growth of 35.7% and is expected to grow at a CAGR of 13.7% during the forecast period. PDMS is a popular polymer in microfluidics because to the numerous benefits it provides. Nontoxicity, resilience, optical transparency, permeability to gas and oxygen, biocompatibility, elastomeric characteristics, low cost, and the ability to stack several layers are some of the benefits of PDMS.
By Technology
Lab-on-a-chip
Medical
Non-Medical
Organs-on-chips
Medical
Non-Medical
Continuous Flow Microfluidics
Medical
Non-Medical
Optofluidics And Microfluidics
Medical
Non-Medical
Acoustofluidics And Microfluidics
Medical
Non-Medical
Electrophoresis And Microfluidics
Medical
Non-Medical
.png)
Need any customization research on Microfluidics Market - Enquiry Now
In 2022, the lab-on-a-chip segment is expected to dominate the market growth of 37.9% and is expected to reveal a CAGR of 11.1% during the forecast period. The lab-on-a-chip enables fast sequencing of DNA probes. Because DNA amplification using the PCR process is dependent on heat cycles, the lab-on-chip performs high-speed thermal changes at the microscale level. Elveflow provides the fastest qPCR system-Fastgene, which identifies bacteria and viruses in 7 minutes. Furthermore, nanopore technologies have greater potential for aiding rapid genome sequencing of DNA probes than actual lab-on-a-chip utilizing an array technique. Similarly, these systems offer profitable potential for immunoassays that can be performed in 10 seconds rather than 10 minutes with macroscopic technology. As a result, activities done using labs-on-a-chip have a high potential for ultra-fast virus and bacterium detection.
North America held a significant market share of over 43.0% in 2022 due to the primary factor driving market growth is an increase in research funding from government organizations and industries. The increased demand for microfluidics devices in research and diagnostics has prompted industry-academia collaboration to speed the commercialization of lab-built devices.
Asia-Pacific is witness to expanding fastest CAGR rate of 16.1% during the forecast period owing to sophisticated research infrastructure, expanding economy, and economical labor. International firms are eager to engage in the undeveloped APAC microfluidics industry. Foreign businesses dominate the market for microfluidic diagnostic tests. However, prominent businesses in the region are presenting unique and intriguing solutions in terms of performance, and more importantly, pricing, which will help them to increase their market share in the next years.
REGIONAL COVERAGE
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The major key players are Illumina, Inc., F. Hoffmann-La Roche Ltd, PerkinElmer, Inc., Agilent Technologies, Inc., HORIBA, Loschmidt laboratory, Bio-Rad Laboratories, Inc., Danaher Corporation, Abbott, Thermo Fisher Scientific, Standard BioTools, BIOLASE, Inc., and Others.
HORIBA, in August 2022, HORIBA established a partnership with SigTuple to accelerate the adoption of its AI100, an AI-assisted digital pathology system, in India. SigTuple used artificial intelligence, robots, microfluidics, and cloud computing to provide smart diagnostic solutions that made quality healthcare more accessible and inexpensive.
BIOLASE, Inc., in January 2022, The EdgePRO system, developed by BIOLASE, Inc. and EdgeEndo, has gained FDA 510(k) clearance for effective disinfection and cleaning within root canal operations.
in March 2021, The Loschmidt laboratory team, in collaboration with ETH Zurich partners, created a microfluidic platform for the effective and speedy analysis of enzymes and their properties.
| Report Attributes | Details |
| Market Size in 2022 | US$ 28.71 Billion |
| Market Size by 2030 | US$ 72.10 Billion |
| CAGR | CAGR of 12.2% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2019-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Application(Medical/Healthcare, Non-medical) • By Material (Silicon, Glass, Polymer, PDMS Others) • By Technology(Lab-on-a-chip, Organs-on-chips, Continuous Flow Microfluidics, Optofluidics and Microfluidics, Acoustofluidics and Microfluidics, Electrophoresis and Microfluidics) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Illumina, Inc., F. Hoffmann-La Roche Ltd, PerkinElmer, Inc., Agilent Technologies, Inc., HORIBA, Loschmidt laboratory, Bio-Rad Laboratories, Inc., Danaher Corporation, Abbott, Thermo Fisher Scientific, Standard BioTools, BIOLASE, Inc. |
| Key Drivers | • Increasing technical advancement |
| Market Opportunity | • Microfluidics is being used to broaden the applicability of medication delivery technology. |
Ans: Medical/Healthcare segment is expected to held the highest market share of 83.8%.
Ans: Microfluidics Market size was valued at USD 28,718 million in 2022.
Ans: Microfluidics Market is anticipated to expand by 12.2% from 2023 to 2030.
Ans: Microfluidics is being used to broaden the applicability of medication delivery technology.
Ans: North America held a significant market share of around 43.0% in 2022.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Microfluidics Market Segmentation, By Application
8.1Medical/Healthcare
8.1.1PCR & RT-PCR
8.1.2Gel Electrophoresis
8.1.3Microarrays
8.1.4ELISA
8.1.5Others
8.2Non-medical
9. Microfluidics Market Segmentation, By Material
9.1Silicon
9.2Glass
9.3Polymer
9.4PDMS
9.5Others Drug Discovery
10. Microfluidics Market Segmentation, By Technology
10.1Lab-on-a-chip
10.1.1Medical
10.1.2Non-Medical
10.2Organs-on-chips
10.2.1Medical
10.2.2Non-Medical
10.3Continuous Flow Microfluidics
10.3.1Medical
10.3.2Non-Medical
10.4Optofluidics and Microfluidics
10.4.1Medical
10.4.2Non-Medical
10.5Acoustofluidics and Microfluidics
10.5.1Medical
10.5.2Non-Medical
10.6Electrophoresis and Microfluidics
10.6.1Medical
10.6.2Non-Medical
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Microfluidics Market by Country
11.2.2 North America Microfluidics Market by Technology
11.2.3 North America Microfluidics Market by Material
11.2.4 North America Microfluidics Market by Application
11.2.5 USA
11.2.5.1 USA Microfluidics Market by Technology
11.2.5.2 USA Microfluidics Market by Material
11.2.5.3 USA Microfluidics Market by Application
11.2.6 Canada
11.2.6.1 Canada Microfluidics Market by Technology
11.2.6.2 Canada Microfluidics Market by Material
11.2.6.3 Canada Microfluidics Market by Application
11.2.7 Mexico
11.2.7.1 Mexico Microfluidics Market by Technology
11.2.7.2 Mexico Microfluidics Market by Material
11.2.7.3 Mexico Microfluidics Market by Application
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Microfluidics Market by Country
11.3.1.2 Eastern Europe Microfluidics Market by Technology
11.3.1.3 Eastern Europe Microfluidics Market by Material
11.3.1.4 Eastern Europe Microfluidics Market by Application
11.3.1.5 Poland
11.3.1.5.1 Poland Microfluidics Market by Technology
11.3.1.5.2 Poland Microfluidics Market by Material
11.3.1.5.3 Poland Microfluidics Market by Application
11.3.1.6 Romania
11.3.1.6.1 Romania Microfluidics Market by Technology
11.3.1.6.2 Romania Microfluidics Market by Material
11.3.1.6.4 Romania Microfluidics Market by Application
11.3.1.7 Turkey
11.3.1.7.1 Turkey Microfluidics Market by Technology
11.3.1.7.2 Turkey Microfluidics Market by Material
11.3.1.7.3 Turkey Microfluidics Market by Application
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Microfluidics Market by Technology
11.3.1.8.2 Rest of Eastern Europe Microfluidics Market by Material
11.3.1.8.3 Rest of Eastern Europe Microfluidics Market by Application
11.3.2 Western Europe
11.3.2.1 Western Europe Microfluidics Market by Technology
11.3.2.2 Western Europe Microfluidics Market by Material
11.3.2.3 Western Europe Microfluidics Market by Application
11.3.2.4 Germany
11.3.2.4.1 Germany Microfluidics Market by Technology
11.3.2.4.2 Germany Microfluidics Market by Material
11.3.2.4.3 Germany Microfluidics Market by Application
11.3.2.5 France
11.3.2.5.1 France Microfluidics Market by Technology
11.3.2.5.2 France Microfluidics Market by Material
11.3.2.5.3 France Microfluidics Market by Application
11.3.2.6 UK
11.3.2.6.1 UK Microfluidics Market by Technology
11.3.2.6.2 UK Microfluidics Market by Material
11.3.2.6.3 UK Microfluidics Market by Application
11.3.2.7 Italy
11.3.2.7.1 Italy Microfluidics Market by Technology
11.3.2.7.2 Italy Microfluidics Market by Material
11.3.2.7.3 Italy Microfluidics Market by Application
11.3.2.8 Spain
11.3.2.8.1 Spain Microfluidics Market by Technology
11.3.2.8.2 Spain Microfluidics Market by Material
11.3.2.8.3 Spain Microfluidics Market by Application
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Microfluidics Market by Technology
11.3.2.9.2 Netherlands Microfluidics Market by Material
11.3.2.9.3 Netherlands Microfluidics Market by Application
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Microfluidics Market by Technology
11.3.2.10.2 Switzerland Microfluidics Market by Material
11.3.2.10.3 Switzerland Microfluidics Market by Application
11.3.2.11.1 Austria
11.3.2.11.2 Austria Microfluidics Market by Technology
11.3.2.11.3 Austria Microfluidics Market by Material
11.3.2.11.4 Austria Microfluidics Market by Application
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Microfluidics Market by Technology
11.3.2.12.2 Rest of Western Europe Microfluidics Market by Material
11.3.2.12.3 Rest of Western Europe Microfluidics Market by Application
11.4 Asia-Pacific
11.4.1 Asia-Pacific Microfluidics Market by Country
11.4.2 Asia-Pacific Microfluidics Market by Technology
11.4.3 Asia-Pacific Microfluidics Market by Material
11.4.4 Asia-Pacific Microfluidics Market by Application
11.4.5 China
11.4.5.1 China Microfluidics Market by Technology
11.4.5.2 China Microfluidics Market by Application
11.4.5.3 China Microfluidics Market by Material
11.4.6 India
11.4.6.1 India Microfluidics Market by Technology
11.4.6.2 India Microfluidics Market by Material
11.4.6.3 India Microfluidics Market by Application
11.4.7 Japan
11.4.7.1 Japan Microfluidics Market by Technology
11.4.7.2 Japan Microfluidics Market by Material
11.4.7.3 Japan Microfluidics Market by Application
11.4.8 South Korea
11.4.8.1 South Korea Microfluidics Market by Technology
11.4.8.2 South Korea Microfluidics Market by Material
11.4.8.3 South Korea Microfluidics Market by Application
11.4.9 Vietnam
11.4.9.1 Vietnam Microfluidics Market by Technology
11.4.9.2 Vietnam Microfluidics Market by Material
11.4.9.3 Vietnam Microfluidics Market by Application
11.4.10 Singapore
11.4.10.1 Singapore Microfluidics Market by Technology
11.4.10.2 Singapore Microfluidics Market by Material
11.4.10.3 Singapore Microfluidics Market by Application
11.4.11 Australia
11.4.11.1 Australia Microfluidics Market by Technology
11.4.11.2 Australia Microfluidics Market by Material
11.4.11.3 Australia Microfluidics Market by Application
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Microfluidics Market by Technology
11.4.12.2 Rest of Asia-Pacific Microfluidics Market by Material
11.4.12.3 Rest of Asia-Pacific Microfluidics Market by Application
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Microfluidics Market by Country
11.5.1.2 Middle East Microfluidics Market by Technology
11.5.1.3 Middle East Microfluidics Market by Material
11.5.1.4 Middle East Microfluidics Market by Application
11.5.1.5 UAE
11.5.1.5.1 UAE Microfluidics Market by Technology
11.5.1.5.2 UAE Microfluidics Market by Material
11.5.1.5.3 UAE Microfluidics Market by Application
11.5.1.6 Egypt
11.5.1.6.1 Egypt Microfluidics Market by Technology
11.5.1.6.2 Egypt Microfluidics Market by Material
11.5.1.6.3 Egypt Microfluidics Market by Application
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Microfluidics Market by Technology
11.5.1.7.2 Saudi Arabia Microfluidics Market by Material
11.5.1.7.3 Saudi Arabia Microfluidics Market by Application
11.5.1.8 Qatar
11.5.1.8.1 Qatar Microfluidics Market by Technology
11.5.1.8.2 Qatar Microfluidics Market by Material
11.5.1.8.3 Qatar Microfluidics Market by Application
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Microfluidics Market by Technology
11.5.1.9.2 Rest of Middle East Microfluidics Market by Material
11.5.1.9.3 Rest of Middle East Microfluidics Market by Application
11.5.2 Africa
11.5.2.1 Africa Microfluidics Market by Country
11.5.2.2 Africa Microfluidics Market by Technology
11.5.2.3 Africa Microfluidics Market by Material
11.5.2.4 Africa Microfluidics Market by Application
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Microfluidics Market by Technology
11.5.2.5.2 Nigeria Microfluidics Market by Material
11.5.2.5.3 Nigeria Microfluidics Market by Application
11.5.2.6 South Africa
11.5.2.6.1 South Africa Microfluidics Market by Technology
11.5.2.6.2 South Africa Microfluidics Market by Material
11.5.2.6.3 South Africa Microfluidics Market by Application
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Microfluidics Market by Technology
11.5.2.7.2 Rest of Africa Microfluidics Market by Material
11.5.2.7.3 Rest of Africa Microfluidics Market by Application
11.6 Latin America
11.6.1 Latin America Microfluidics Market by Country
11.6.2 Latin America Microfluidics Market by Technology
11.6.3 Latin America Microfluidics Market by Material
11.6.4 Latin America Microfluidics Market by Application
11.6.5 Brazil
11.6.5.1 Brazil Microfluidics Market by Technology
11.6.5.2 Brazil Microfluidics Market by Material
11.6.5.3 Brazil Microfluidics Market by Application
11.6.6 Argentina
11.6.6.1 Argentina Microfluidics Market by Technology
11.6.6.2 Argentina Microfluidics Market by Material
11.6.6.3 Argentina Microfluidics Market by Application
11.6.7 Colombia
11.6.7.1 Colombia Microfluidics Market by Technology
11.6.7.2 Colombia Microfluidics Market by Material
11.6.7.3 Colombia Microfluidics Market by Application
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Microfluidics Market by Technology
11.6.8.2 Rest of Latin America Microfluidics Market by Material
11.6.8.3 Rest of Latin America Microfluidics Market by Application
12.Company profile
12.1 Illumina, Inc.
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Technologys/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Technology/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 PerkinElmer, Inc.
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Technology/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Agilent Technologies, Inc.
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Technology/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 HORIBA
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Technology/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Loschmidt laboratory
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Technology/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Bio-Rad Laboratories Inc.
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Technology/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Danaher Corporation
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Technology/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Abbott
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Technology/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Thermo Fisher Scientific
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Technology/Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
12.11 Standard BioTools
12.11.1 Company Overview
12.11.2 Financials
12.11.3 Technology/Services Offered
12.11.4 SWOT Analysis
12.11.5 The SNS View
13.12 BIOLASE, Inc.
12.12.1 Company Overview
12.12.2 Financials
12.12.3 Technology/Services Offered
12.12.4 SWOT Analysis
12.12.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Dental Bone Grafts and Substitutes Market was valued at USD 820.06 million in 2022, and it is predicted to reach 1.97 billion in 2030 at a CAGR of 11.2 % from 2023 to 2030.
The Healthcare Consulting Services Market Size was valued at USD 26.70 billion in 2022, and is expected to reach USD 65.21 billion by 2030, and grow at a CAGR of 11.8% over the forecast period 2023-2030.
The Biohacking Market size was valued at USD 22.17 billion in 2022 and is expected to reach at USD 90.36 billion by 2030, and grow at a CAGR of 19.2% over the forecast period of 2023-2030.
The Biobanking Market Size was valued at USD 48.65 billion in 2022, and is expected to reach USD 86.77 billion by 2030 and grow at a CAGR of 7.5% over the forecast period 2023-2030.
The Neuroendoscopy Market size is projected to grow from $151.07 million in 2023 to $237.05 million by 2031, at a CAGR of 5.8% during the forecast period.
The Opioid Use Disorder Market size was valued at USD 3.13 billion in 2022 and it is expected to be worth around USD 6.15 billion by 2030 growing at a remarkable GAGR of 8.8% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
